CoChat
Sign Up
Cited by 66Substance Abuse Treatment and OutcomesHealth Systems, Economic Evaluations, Quality of LifeOpioid Use Disorder Treatment

Using the DATCAP and ASI to estimate the costs and benefits of residential addiction treatment in the State of Washington

French, Michael T., Salomé, Helena J., Carney, Molly·2002·Social Science & Medicine
DOI 10.1016/s0277-9536(02)00060-6
Open this paper in CoChat — free account

Abstract

Funding agencies and policy makers often criticize residential addiction treatment because the cost of residential services is typically higher than for outpatient services and it is unclear whether the outcomes are significantly better for most clients. To address these concerns, proponents of residential treatment require economic evidence to justify further investments in this modality over less intensive and less costly options. Recent studies have developed methods and empirical guidelines for using the drug abuse treatment cost analysis program (DATCAP) and the addiction severity index (ASI) in a comprehensive economic evaluation of addiction treatment. The present study applied these methods and guidelines to estimate the economic costs and benefits of residential addiction treatment at five programs in the State of Washington, USA that serve publicly funded clients. Program- and client-specific economic cost estimates were derived using data collected on-site with the DATCAP along with opportunity cost estimates associated with treatment attendance. Economic benefits were calculated from client self-reported information at treatment entry and at 6 months post discharge using the ASI. Outcome categories included inpatient services, employment, medical and psychiatric conditions, and criminal activity. Results indicate that average weekly economic cost of treatment services at the five programs ranged from 463 dollars to 703 dollars. Average (per client) economic cost o…

Integrity signals

Registry

Crossref · 10.1016/s0277-9536(02)00060-6

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The monetary conversion factors for a day with medical, psychological, or psychiatric problems are derived using DATCAP and ASI measures, drawing on value-of-statistical-life and QALY literature with a VSL of $1 million.

    “These MCFs draw from the literature on the value of a statistical life (VSL) (Viscusi & Aldy, 2003) and quality-adjusted life-years (QALYs) (Mehrez & Gafni, 1989) to project the cost per one-unit decrement in a quality-adjusted life-day based on a VSL of $1 million.”

    From Monetary conversion factors for economic evaluations of substance use disorders (2017) · cites this paper as French, Salome, & Carney, 2002

  • A day experiencing psychological or psychiatric problems is valued at $19.

    “A day experiencing medical problems is valued at $50 and a day experiencing psychological or psychiatric problems is valued at $19.”

    From Monetary conversion factors for economic evaluations of substance use disorders (2017) · cites this paper as French, Salome, & Carney, 2002

  • A day experiencing medical problems is valued at $50.

    “A day experiencing medical problems is valued at $50 and a day experiencing psychological or psychiatric problems is valued at $19.”

    From Monetary conversion factors for economic evaluations of substance use disorders (2017) · cites this paper as French, Salome, & Carney, 2002

  • The cost per day of engaging in unspecified illegal activity is $1,011, based on French et al. (2002).

    “The cost per day of engaging in unspecified illegal activity, a measure from the ASI, was estimated to be $1,011, based on French et al. (2002) (French, Salome, & Carney, 2002).”

    From Monetary conversion factors for economic evaluations of substance use disorders (2017) · cites this paper as French, Salome, & Carney, 2002

Cites

Flagged first, then by citations

2 of the 56 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Related

Authors
French, M. T., Salomé, H. J., & Carney, M.
Affiliations
  • University of Miami (US)
  • University of Washington (US)
Corresponding author
French, Michael T.
ORCID
French, Michael T.
Venue
Social Science & Medicine
Publisher
Elsevier BV
Published
2002-12
Volume
55
Issue
12
Pages
2267-2282
ISSN
0277-9536 (ISSN-L)
DOI
10.1016/s0277-9536(02)00060-6
OpenAlex
W1977017873
Cited by
66
References
56
Citations by year
2025: 1 · 2023: 1 · 2022: 1 · 2021: 1 · 2019: 1 · 2018: 2 · 2017: 3 · 2015: 1 · 2014: 1 · 2013: 2 · 2012: 2
FWCI
5.53
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Social Science & Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
Funders
  • University of Washington
  • National Institute on Drug Abuse (1R01 DA11506, P50DA007705, R01DA011506, 3P50 DA07705)
Topics
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
Keywords
residential addiction treatment, Addiction Severity Index, economic evaluation, cost-benefit analysis, treatment costs, treatment outcomes, government funding, benefit-cost ratio, substance use disorders, Washington State
MeSH terms
Adult, Cost-Benefit Analysis, Female, Health Services Research, Humans, Male, Public Assistance, Residential Treatment, Severity of Illness Index, State Health Plans, United States, Washington, Program Evaluation, Substance Abuse Treatment Centers, Health Care Costs, Outcome Assessment, Health Care, Quality-Adjusted Life Years, Substance-Related Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review